The C2A domain of synaptotagmin is an essential component of the calcium sensor for synaptic transmission.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 22 11 2019
accepted: 13 01 2020
entrez: 8 2 2020
pubmed: 8 2 2020
medline: 25 4 2020
Statut: epublish

Résumé

The synaptic vesicle protein, synaptotagmin, is the principle Ca2+ sensor for synaptic transmission. Ca2+ influx into active nerve terminals is translated into neurotransmitter release by Ca2+ binding to synaptotagmin's tandem C2 domains, triggering the fast, synchronous fusion of multiple synaptic vesicles. Two hydrophobic residues, shown to mediate Ca2+-dependent membrane insertion of these C2 domains, are required for this process. Previous research suggested that one of its tandem C2 domains (C2B) is critical for fusion, while the other domain (C2A) plays only a facilitatory role. However, the function of the two hydrophobic residues in C2A have not been adequately tested in vivo. Here we show that these two hydrophobic residues are absolutely required for synaptotagmin to trigger vesicle fusion. Using in vivo electrophysiological recording at the Drosophila larval neuromuscular junction, we found that mutation of these two key C2A hydrophobic residues almost completely abolished neurotransmitter release. Significantly, mutation of both hydrophobic residues resulted in more severe deficits than those seen in synaptotagmin null mutants. Thus, we report the most severe phenotype of a C2A mutation to date, demonstrating that the C2A domain is absolutely essential for synaptotagmin's function as the electrostatic switch.

Identifiants

pubmed: 32032373
doi: 10.1371/journal.pone.0228348
pii: PONE-D-19-32484
pmc: PMC7006929
doi:

Substances chimiques

Drosophila Proteins 0
Neurotransmitter Agents 0
Synaptotagmins 134193-27-4
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0228348

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

EMBO J. 1998 Jul 15;17(14):3921-30
pubmed: 9670009
Nat Struct Mol Biol. 2018 Oct;25(10):911-917
pubmed: 30291360
Biochemistry. 2006 Aug 15;45(32):9668-74
pubmed: 16893168
Nature. 2001 Mar 1;410(6824):41-9
pubmed: 11242035
Mol Biol Cell. 2006 Dec;17(12):5211-26
pubmed: 16987956
J Biol Chem. 2011 Jul 15;286(28):25291-300
pubmed: 21610074
Biochemistry. 2017 Jan 10;56(1):281-293
pubmed: 27997124
J Neurochem. 1994 Jul;63(1):41-51
pubmed: 8207445
J Biol Chem. 1998 Jul 24;273(30):19093-6
pubmed: 9668093
Neuron. 1994 Apr;12(4):909-20
pubmed: 7909234
J Biol Chem. 2006 Jun 9;281(23):15845-52
pubmed: 16595652
Cell. 1994 Nov 18;79(4):717-27
pubmed: 7954835
J Neurosci. 2009 Jun 10;29(23):7395-403
pubmed: 19515907
J Neurosci. 2011 Feb 9;31(6):2248-57
pubmed: 21307261
Nature. 2002 Jul 18;418(6895):340-4
pubmed: 12110842
Genesis. 2009 May;47(5):337-45
pubmed: 19358157
J Biol Chem. 1998 May 29;273(22):13995-4001
pubmed: 9593749
Neuron. 2001 Dec 20;32(6):1057-69
pubmed: 11754837
Cell. 1993 Jul 2;73(7):1281-90
pubmed: 8100740
J Biol Chem. 1991 Jan 5;266(1):615-22
pubmed: 1840599
J Neurosci. 2012 Jan 25;32(4):1253-60
pubmed: 22279210
Mol Cell. 2002 Jan;9(1):145-54
pubmed: 11804593
J Neurosci. 2008 Jul 23;28(30):7458-66
pubmed: 18650324
Diabetes. 2002 Feb;51 Suppl 1:S12-8
pubmed: 11815451
Cell. 1993 Sep 24;74(6):1125-34
pubmed: 8104705
Nature. 2002 Jul 18;418(6895):336-40
pubmed: 12110845
Annu Rev Physiol. 2002;64:355-405
pubmed: 11826273
Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1665-70
pubmed: 11805296
J Physiol. 1967 Nov;193(2):419-32
pubmed: 6065887
Cell. 2009 Aug 21;138(4):709-21
pubmed: 19703397
J Cell Biol. 2004 Jul 19;166(2):249-60
pubmed: 15263020
Neuron. 2003 Jul 17;39(2):299-308
pubmed: 12873386
J Neurogenet. 2004 Apr-Jun;18(2):377-402
pubmed: 15763995
J Cell Biol. 1999 Nov 1;147(3):589-98
pubmed: 10545502
Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10727-31
pubmed: 7938019
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18664-9
pubmed: 16352718
J Neurosci. 2004 Sep 29;24(39):8542-50
pubmed: 15456828
J Neurosci. 2002 Oct 1;22(19):8438-46
pubmed: 12351718
Mol Biol Cell. 2008 Dec;19(12):5093-103
pubmed: 18799625
Science. 1992 May 15;256(5059):1021-5
pubmed: 1589771
J Comp Neurol. 2001 Jul 16;436(1):4-16
pubmed: 11413542
Mol Cell Neurosci. 2005 Jul;29(3):462-70
pubmed: 15886015
Development. 1993 Jun;118(2):401-15
pubmed: 8223268
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3312-7
pubmed: 17360644
Nat Struct Mol Biol. 2004 Jan;11(1):36-44
pubmed: 14718921
Genesis. 2001 Sep;31(1):30-6
pubmed: 11668675
Science. 2007 May 25;316(5828):1205-8
pubmed: 17478680
J Biol Chem. 2003 Nov 21;278(47):47030-7
pubmed: 12963743

Auteurs

Matthew R Bowers (MR)

Department of Biomedical Sciences, Molecular, Cellular, Integrative Neurosciences Program, Colorado State University, Fort Collins, CO, United States of America.

Noreen E Reist (NE)

Department of Biomedical Sciences, Molecular, Cellular, Integrative Neurosciences Program, Colorado State University, Fort Collins, CO, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH